Table 2:

Percentage of Responders in each arm

Dose	CGI	Placebo Group Average Slope Discriminant (PGASD) Criterion
		Observed	PPR
Placebo	37.8%	35.7%	35.7%
20 mg	57.1%	59.2%	38.3%
40 mg	58.9%	57.8%	40.1%